Genetics of Wilsons disease

Parkinsonism and Related Disorders

Volumn 16, Issue 10, 2010, Pages 639-644

  Behari, Madhuri ^a   Pardasani, Vibhor ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

Author keywords

ATP7B; Brain; Genes; Hepatic; Mutations; Wilson's disease

Indexed keywords

CERULOPLASMIN; COPPER; COPPER EXPORTING ADENOSINE TRIPHOSPHATASE;

AMINO ACID SUBSTITUTION; ATP7B GENE; AUTOSOMAL RECESSIVE DISORDER; CHROMOSOME 13Q; EARLY DIAGNOSIS; ETHNIC GROUP; GENE; GENE MUTATION; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; GEOGRAPHIC DISTRIBUTION; HUMAN; LINKAGE ANALYSIS; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW; TRANS GOLGI NETWORK; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; ADULT; BILE; CATION TRANSPORT PROTEINS; CHILD; COPPER; ETHNIC GROUPS; GENETIC TESTING; HEPATOLENTICULAR DEGENERATION; HUMANS; MUTATION; PHENOTYPE;

EID: 78649744442     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.07.007     Document Type: Review

References (83)

1. Scheinberg I.H., Sternlieb I. Wilson's disease. Major problems in internal medicine 1984, 171. Saunders, Philadelphia. L.H.J. Smith (Ed.).
2. Ala A., Walker A.P., Ashkan K., Dooley J.S., Schilsky M.L. Wilson's disease. Lancet 2007, 369(9559):397-408.
3. Gitlin J.D. Wilson disease. Gastroenterology 2003, 125(6):1868-1877.
4. Scheinberg I.H., Gitlin D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science 1952, 116(3018):484-485.
5. Bowcock A.M., Farrer L.A., Hebert J.M., Agger M., Sternlieb I., Scheinberg I.H., et al. Eight closely linked loci place the Wilson disease locus within 13q14-q21. Am J Hum Genet 1988, 43(5):664-674.
6. Frydman M., Bonné-Tamir B., Farrer L.A., Conneally P.M., Magazanik A., Ashbel S., et al. Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus. Proc Natl Acad Sci U S A 1985, 82(6):1819-1821.
7. Tanzi R.E., Petrukhin K., Chernov I., Pellequer J.L., Wasco W., Ross B., et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993, 5(4):344-350.
8. Bull P.C., Cox D.W. Wilson disease and Menkes disease: new handles on heavy-metal transport. Trends Genet 1994, 10(7):246-252.
9. Bull P.C., Thomas G.R., Rommens J.M., Forbes J.R., Cox D.W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993, 5(4):327-337.
10. Thomas G.R., Forbes J.R., Roberts E.A., Walshe J.M., Cox D.W. The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet 1995, 9(2):210-217.
11. Kenney S.M., Cox D.W. Sequence variation database for the Wilson disease copper transporter, ATP7B. Hum Mutat 2007, 28(12):1171-1177. http://www.wilsondisease.med.ualberta.ca/database.asp.
12. Loudianos G., Gitlin J.D. Wilson's disease. Semin Liver Dis 2000, 20(3):353-364.
13. Figus A., Angius A., Loudianos G., Bertini C., Dessi V., Loi A., et al. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations. Am J Hum Genet 1995, 57(6):1318-1324.
14. Shah A.B., Chernov I., Zhang H.T., Ross B.M., Das K., Lutsenko S., et al. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 1997, 61(2):317-328.
15. Ferenci P. Wilson's disease. Clin Gastroenterol Hepatol 2005, 3(8):726-733.
16. Chuang L.M., Wu H.P., Jang M.H., Wang T.R., Sue W.C., Lin B.J., et al. High frequency of two mutations in codon 778 in exon 8 of the ATP7B gene in Taiwanese families with Wilson disease. J Med Genet 1996, 33(6):521-523.
17. Nanji M.S., Nguyen V.T., Kawasoe J.H., Inui K., Endo F., Nakajima T., et al. Haplotype and mutation analysis in Japanese patients with Wilson disease. Am J Hum Genet 1997, 60(6):1423-1429.
18. Kim E.K., Yoo O.J., Song K.Y., Yoo H.W., Choi S.Y., Cho S.W., et al. Identification of three novel mutations and a high frequency of the Arg778Leu mutation in Korean patients with Wilson disease. Hum Mutat 1998, 11(4):275-278.
19. Wu Z.Y., Wang N., Lin M.T., Fang L., Murong S.X., Yu L. Mutation analysis and the correlation between genotype and phenotype of Arg778Leu mutation in Chinese patients with Wilson disease. Arch Neurol 2001, 58(6):971-976.
20. Yamaguchi Y., Heiny M.E., Gitlin J.D. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun 1993, 197(1):271-277.
21. Petrukhin K., Lutsenko S., Chernov I., Ross B.M., Kaplan J.H., Gilliam T.C. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet 1994, 3(9):1647-1656.
22. Petrukhin K., Fischer S.G., Pirastu M., Tanzi R.E., Chernov I., Devoto M., et al. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet 1993, 5(4):338-343.
23. Michalczyk A.A., Rieger J., Allen K.J., Mercer J.F., Ackland M.L. Defective localization of the Wilson disease protein (ATP7B) in the mammary gland of the toxic milk mouse and the effects of copper supplementation. Biochem J 2000, 352:565-571.
24. Schaefer M., Roelofsen H., Wolters H., Hofmann W.J., Müller M., Kuipers F., et al. Localization of the Wilson's disease protein in human liver. Gastroenterology 1999, 117(6):1380-1385.
25. Harada M., Kawaguchi T., Kumemura H., Terada K., Ninomiya H., Taniguchi E., et al. The Wilson disease protein ATP7B resides in the late endosomes with Rab7 and the Niemann-Pick C1 protein. Am J Pathol 2005, 166(2):499-510.
26. Lutsenko S., Cooper M.J. Localization of the Wilson's disease protein product to mitochondria. Proc Natl Acad Sci U S A 1998, 95(11):6004-6009.
27. Terada K., Aiba N., Yang X.L., Iida M., Nakai M., Miura N., et al. Biliary excretion of copper in LEC rat after introduction of copper transporting P-type ATPase, ATP7B. FEBS Lett 1999, 448(1):53-56.
28. Roelofsen H., Wolters H., Van Luyn M.J., Miura N., Kuipers F., Vonk R.J. Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion. Gastroenterology 2000, 119(3):782-793.
29. Riordan S.M., Williams R. The Wilson's disease gene and phenotypic diversity. J Hepatol 2001, 34(1):165-171.
30. Fatemi N., Sarkar B. Molecular mechanism of copper transport in Wilson disease. Environ Health Perspect 2002, 5(Suppl. 110):695-698.
31. Fatemi N., Sarkar B. Structural and functional insights of Wilson disease copper-transporting ATPase. J Bioenerg Biomembr 2002, 34(5):339-349.
32. Cater M.A., Forbes J., La Fontaine S., Cox D., Mercer J.F. Intracellular trafficking of the human Wilson protein: the role of the six N-terminal metal-binding sites. Biochem J 2004, 380:805-813.
33. DiDonato M., Hsu H.F., Narindrasorasak S., Que L., Sarkar B. Copper-induced conformational changes in the N-terminal domain of the Wilson disease copper-transporting ATPase. Biochemistry 2000, 39(7):1890-1896.
34. Vanderwerf S.M., Cooper M.J., Stetsenko I.V., Lutsenko S. Copper specifically regulates intracellular phosphorylation of the Wilson's disease protein, a human copper-transporting ATPase. J Biol Chem 2001, 276(39):36289-36294.
35. Dmitriev O., Tsivkovskii R., Abildgaard F., Morgan C.T., Markley J.L., Lutsenko S. Solution structure of the N-domain of Wilson disease protein: distinct nucleotide-binding environment and effects of disease mutations. Proc Natl Acad Sci U S A 2006, 103(14):5302-5307.
36. Morgan C.T., Tsivkovskii R., Kosinsky Y.A., Efremov R.G., Lutsenko S. The distinct functional properties of the nucleotide-binding domain of ATP7B, the human copper-transporting ATPase: analysis of the Wilson disease mutations E1064A, H1069Q, R1151H, and C1104F. J Biol Chem 2004, 279(35):36363-36371.
37. Schilsky M., Tavill A.S. Wilson disease. Disease of the liver 2003, 1169-1186. Lippincott Williams & Wilkins, Philadelphia. 9th ed. E.R. Schiff (Ed.).
38. Sherlock S., Dooley J. Diseases of the liver and biliary system 2002, Blackwell Science, Oxford.
39. Mufti A.R., Burstein E., Csomos R.A., Graf P.C., Wilkinson J.C., Dick R.D., et al. XIAP Is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders. Mol Cell 2006, 21(6):775-785.
40. Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet 2006, 120(2):151-159.
41. Ferenci P., Merle U., FolhoVer A., Evstatiev R., Yurdaydin C., Bruha R., et al. Phenotype-genotype correlations in Wilson Disease (WD)-results of a multinational study. Hepatology 2005, 42(Suppl. 1):258A.
42. Caca K., Ferenci P., Kuhn H.J., Polli C., Willgerodt H., Kunath B., et al. High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol 2001, 35:575-581.
43. Curtis D., Durkie M., Balac P., Sheard D., Goodeve A., Peake I., et al. A study of Wilson disease mutations in Britain. Hum Mutat 1999, 14:304-311.
44. Vrabelova S., Letocha O., Borsky M., Kozak L. Mutation analysis of the ATP7B gene and genotype/phenotype correlation in 227 patients with Wilson disease. Genet Metab 2005, 86:277-285.
45. Firneisz G., Lakatos P.L., Szalay F., Polli C., Glant T.T., Ferenci P. Common mutations of ATP7B in Wilson disease patients from Hungary. Am J Med Genet 2002, 108:23-28.
46. Loudianos G., Kostic V., Solinas P., Lovicu M., Dessi V., Svetel M., et al. Characterization of the molecular defect in the ATP7B gene in Wilson disease patients from Yugoslavia. Genet Test 2003, 7:107-112.
47. Gromadzka G., Schmidt H.H., Genschel J., Bochow B., Rodo M., Tarnacka B., et al. Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease. Clin Genet 2005, 68(6):524-532.
48. Ivanova-Smolenskaya I.A., Ovchinnikov I.V., Karabanov A.V., Deineko N.L., Poleshchuk V.V., Markova E.D., et al. The His1069Gln mutation in the ATP7B gene in Russian patients with Wilson disease. J Med Genet 1999, 36:174.
49. Todorov T., Savov A., Jelev H., Panteleeva E., Konstantinova D., Krustev Z., et al. Spectrum of mutations in the Wilson disease gene (ATP7B) in the Bulgarian population. Clin Genet 2005, 68:474-476.
50. Loudianos G., Dessi V., Lovicu M., Angius A., Nurchi A., Sturniolo G.C., et al. Further delineation of the molecular pathology of Wilson disease in the Mediterranean population. Hum Mutat 1998, 12:89-94.
51. Loudianos G., Dessi V., Lovicu M., Angius A., Altuntas B., Giacchino R., et al. Mutation analysis in patients of Mediterranean descent with Wilson disease: identification of 19 novel mutations. J Med Genet 1999, 36:833-836.
52. Panagiotakaki E., Tzetis M., Manolaki N., Loudianos G., Papatheodorou A., Manesis E., et al. Genotype-phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B). Am J Med Genet A 2004, 131(2):168-173.
53. Gu Y.H., Kodama H., Du S.L., Gu Q.J., Sun H.J., Ushijima H. Mutation spectrum and polymorphisms in ATP7B identified on direct sequencing of all exons in Chinese Han and Hui ethnic patients with Wilson's disease. Clin Genet 2003, 64:479-484.
54. Wu Z., Wang N., Murong S., Lin M. Identification and analysis of mutations of the Wilson disease gene in Chinese population. Chin Med J (Engl) 2000, 113:40-43.
55. Liu X.Q., Zhang Y.F., Liu T.T., Hsiao K.J., Zhang J.M., Gu X.F., et al. Correlation of ATP7B genotype with phenotype in Chinese patients with Wilson disease. World J Gastroenterol 2004, 10(4):590-593.
56. Figus A., Angius A., Loudianos O., Bertini C., Dessi V., Loi A., et al. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations. Am J Hum Genet 1995, 57:1318-1324.
57. Loudianos G., Dessi V., Lovicu M., Angius A., Figus A., Lilliu F., et al. Molecular characterization of Wilson disease in the Sardinian population-evidence of a founder effect. Hum Mutat 1999, 14(4):294-303.
58. Margarit E., Bach V., Gomez D., Bruguera M., Jara P., Queralt R., et al. Mutation analysis of Wilson disease in the Spanish population-identification of a prevalent substitution and eight novel mutations in the ATP7B gene. Clin Genet 2005, 68:61-68.
59. Garcia-Villareal L., Daniels S., Shaw S.H., Cotton D., Galvin M., Geskes J., et al. High prevalence of the very rare Wilson disease gene mutation Leu708Pro in the Island of Gran Canaria (Canary Islands. Spain): a genetic and clinical study. Hepatology 2000, 32:1329-1336.
60. Deguti M.M., Genschel J., Cancado E.L., Barbosa E.R., Bochow B., Mucenic M., et al. Wilson disease: novel mutations in the ATP7B gene and clinical correlation in Brazilian patients. Hum Mutat 2004, 398:1-8.
61. Al Jumah M., Majumdar R., Al Rajeh S., Awada A., Al Zaben A., Al Traif I., et al. Clinical and genetic study of 56 Saudi Wilson disease patients: identification of Saudi-specific mutations. Eur J Neurol 2004, 11:121-124.
62. Gupta A., Aikath D., Neogi R., Datta S., Basu K., Maity B., et al. Molecular pathogenesis of Wilson disease: haplotype analysis, detection of prevalent mutations and genotype-phenotype correlation in Indian patients. Hum Genet 2005, 118(1):49-57.
63. Kumar S., Thapa B.R., Kaur G., Prasad R. Identification and molecular characterization of 18 novel mutations in the ATP7B gene from Indian Wilson disease patients: genotype. Identification and molecular characterization of 18 novel mutations in the ATP7B gene from Indian Wilson disease patients: genotype. Clin Genet 2005, 67(5):443-445.
64. Okada T., Shiono Y., Hayashi H., Satoh H., Sawada T., Suzuki A., et al. Mutational analysis of ATP7B and genotype-phenotype correlation in Japanese with Wilson's disease. Hum Mutat 2000, 15(5):454-462.
65. Shimizu N., Kawase C., Nakazono H., Hemmi H., Shimatake H., Aoki T. A novel RNA splicing mutation in Japanese patients with Wilson disease. Biochem Biophys Res Commun 1995, 217:16-20.
66. Stapelbroek J.M., Bollen C.W., van Amstel J.K., van Erpecum K.J., van Hattum J., van den Berg L.H., et al. The H1069Q mutation in ATP7B is associated with late and neurologic presentation in Wilson disease: results of a meta-analysis. J Hepatol 2004, 41(5):758-763.
67. Cullen L.M., Prat L., Cox D.W. Genetic variation in the promoter and 5' UTR of the copper transporter, ATP7B, in patients with Wilson disease. Clin Genet 2003, 64(5):429-432.
68. Møller L.B., Ott P., Lund C., Horn N. Homozygosity for a gross partial gene deletion of the C-terminal end of ATP7B in a Wilson patient with hepatic and no neurological manifestations. Am J Med Genet A 2005, 138(4):340-343.
69. De Bie P., Muller P., Wijmenga C., Klomp L.W. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J Med Genet 2007, 44(11):673-688.
70. Mak C.M., Lam C.W., Tam S., Lai C.L., Chan L.Y., Fan S.T., et al. Mutational analysis of 65 Wilson disease patients in Hong Kong Chinese: identification of 17 novel mutations and its genetic heterogeneity. J Hum Genet 2008, 53(1):55-63.
71. Santhosh S., Shaji R.V., Eapen C.E., Jayanthi V., Malathi S., Chandy M., et al. ATP7B mutations in families in a predominantly Southern Indian cohort of Wilson's disease patients. Indian J Gastroenterol 2006, 25(6):277-282.
72. Siddiqui S.N., Thelma B.K., Vivekanandhan S., Goyal V., Jain D.C., Acharya S.K., et al. Identification of mutations in the P-type ATPase (ATP7B) gene responsible for Wilson's disease (WD) for exon 18 in the North Indian population. Mov Disord 2008, vol. 23(Suppl. 1):S48.
73. Leggio L., Malandrino N., Loudianos G., Abenavoli L., Lepori M.B., Capristo E., et al. Analysis of the T1288R mutation of the Wilson disease ATP7B gene in four generations of a family: possible genotype-phenotype correlation with hepatic onset. Dig Dis Sci 2007, 52(10):2570-2575.
74. Houwen R.H., Juyn J., Hoogenraad T.U., Ploos van Amstel J.K., Berger R. H714Q mutation in Wilson disease is associated with late, neurological presentation. J Med Genet 1995, 32(6):480-482.
75. Schiefermeier M., Kollegger H., Madl C., Polli C., Oder W., Kühn H., et al. The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain 2000, 123:585-590.
76. Coronado V.A., Bonneville J.A., Nazer H., Roberts E.A., Cox D.W. COMMD1 (MURR1) as a candidate in patients with copper storage disease of undefined etiology. Clin Genet 2005, 68(6):548-551.
77. Tao T.Y., Liu F., Klomp L., Wijmenga C., Gitlin J.D. The copper toxicosis gene product Murr1 directly interacts with the Wilson disease protein. J Biol Chem 2003, 278(43):41593-41596.
78. Müller T., van de Sluis B., Zhernakova A., van Binsbergen E., Janecke A.R., Bavdekar A., et al. The canine copper toxicosis gene MURR1 does not cause non-Wilsonian hepatic copper toxicosis. J Hepatol 2003, 38(2):164-168.
79. Weiss K.H., Merle U., Schaefer M., Ferenci P., Fullekrug J., Stremmel W. Copper toxicosis gene MURR1 is not changed in Wilson disease patients with normal blood ceruloplasmin levels. World J Gastroenterol 2006, 12(14):2239-2242.
80. Klomp A.E., van de Sluis B., Klomp L.W., Wijmenga C. The ubiquitously expressed MURR1 protein is absent in canine copper toxicosis. J Hepatol 2003, 39(5):703-709.
81. Wu Z.Y., Zhao G.X., Chen W.J., Wang N., Wan B., Lin M.T., et al. Mutation analysis of 218 Chinese patients with Wilson disease revealed no correlation between the canine copper toxicosis gene MURR1 and Wilson disease. J Mol Med 2006, 84(5):438-442.
82. Walshe J.M. Diagnosis and treatment of presymptomatic Wilson's disease. Lancet 1988, 2(8608):435-437.
83. Loudianos G., Figus A.L., Loi A., Angius A., Dessì V., Deiana M. Improvement of prenatal diagnosis of Wilson disease using microsatellite markers. Prenat Diagn 1994, 14(10):999-1002.